{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:01:12Z","timestamp":1791284472848,"version":"4.1.0"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083431","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T21:59:54Z","timestamp":1388527194000},"page":"e83431","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil\u2122 in Adult Women"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct00090220","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joaquin","family":"Luna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivete","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Nossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Radley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Vuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Haupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Saah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JMM Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"N Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"ref3","unstructured":"International Agency for Research on Cancer Working Group (2007) Human Papillomaviruses."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"EF Dunne","year":"2007","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"M Schiffman","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","article-title":"Distribution of 37 mucosotropic HPV types in women with cytologically normal cervial smears: the age-related patterns for high-risk and low-risk types","volume":"87","author":"MV Jacobs","year":"2000","journal-title":"Int J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"RL Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2009.09.021","article-title":"HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives","volume":"115","author":"X Castellsague","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"AR Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial","volume":"373","author":"N Munoz","year":"2009","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age","volume":"105","author":"X Castellsague","year":"2011","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4161\/hv.4.2.5261","article-title":"Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11","volume":"4","author":"JF Smith","year":"2008","journal-title":"Hum Vaccin"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4161\/hv.7.2.13948","article-title":"The humoral response to Gardasil(R) over four years as defined by Total IgG and competitive Luminex immunoassay","volume":"7","author":"DR Brown","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/599988","article-title":"Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials","volume":"200","author":"JT Schiller","year":"2009","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/jis406","article-title":"Vaccine-relevant human papillomavirus (HPV) infections and future acquisition of high-risk HPV types in men","volume":"206","author":"AF Rositch","year":"2012","journal-title":"J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:01:26Z","timestamp":1540339286000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083431"}},"subtitle":[],"editor":[{"given":"Sarah","family":"Pett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083431","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}